Get started
HISAMITSU PHARMACEUTICAL CO. INC.HISAMITSU PHARMACEUTICAL CO. INC.HISAMITSU PHARMACEUTICAL CO. INC.

HISAMITSU PHARMACEUTICAL CO. INC.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

4530 chart

Key stats

Market capitalization
‪302.10 B‬JPY
Dividend yield (indicated)
2.37%
Price to earnings Ratio (TTM)
30
Basic EPS (TTM)
180JPY
Net income
‪13.97 B‬JPY
Revenue
‪141.71 B‬JPY
Shares float
‪34.12 M‬
Beta (1Y)
0.28

About HISAMITSU PHARMACEUTICAL CO. INC.

Sector
Health Technology
Headquarters
Tosu
Founded
1847
Website
hisamitsu.co.jp
ISIN
JP3784600003
FIGI
BBG000BG6PR0
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 4530 is 5080.00 JPY — it has decreased by 5.58% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NAG exchange HISAMITSU PHARMACEUTICAL CO. INC. stocks are traded under the ticker 4530.
HISAMITSU PHARMACEUTICAL CO. INC. is going to release the next earnings report on Jul 4, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for HISAMITSU PHARMACEUTICAL CO. INC. has a max estimate of 4250.00 JPY and a min estimate of 4250.00 JPY.
4530 earnings for the last quarter are 20.46 JPY whereas the estimation was 22.20 JPY which accounts for −7.84% surprise. Estimated earnings for the next quarter are 19.40 JPY. See more details about HISAMITSU PHARMACEUTICAL CO. INC. earnings.
HISAMITSU PHARMACEUTICAL CO. INC. revenue for the last quarter amounts to ‪32.10 B‬ JPY despite the estimated figure of ‪31.00 B‬ JPY. In the next quarter revenue is expected to reach ‪66.98 B‬ JPY.
Yes, you can track HISAMITSU PHARMACEUTICAL CO. INC. financials in yearly and quarterly reports right on TradingView.
Like other stocks, 4530 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HISAMITSU PHARMACEUTICAL CO. INC. stock right from TradingView charts — choose your broker and connect to your account.
4530 reached its all-time high on Nov 30, 2018 with the price of 7080.00 JPY, and its all-time low was 2725.00 JPY and was reached on Feb 24, 2006.
See other stocks reaching their highest and lowest prices.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HISAMITSU PHARMACEUTICAL CO. INC. EBITDA is ‪18.26 B‬ JPY, and current EBITDA margin is 12.94%. See more stats in HISAMITSU PHARMACEUTICAL CO. INC. financial statements.